• Je něco špatně v tomto záznamu ?

(±)-BIGI-3h: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3β Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer's Disease

L. Ismaili, J. Monnin, A. Etievant, RL. Arribas, L. Viejo, B. Refouvelet, O. Soukup, J. Janockova, V. Hepnarova, J. Korabecny, T. Kucera, D. Jun, R. Andrys, K. Musilek, A. Baguet, EM. García-Frutos, A. De Simone, V. Andrisano, M. Bartolini, C. de...

. 2021 ; 12 (8) : 1328-1342. [pub] 20210402

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21018798

Multitarget-directed ligands (MTDLs) are considered a promising therapeutic strategy to address the multifactorial nature of Alzheimer's disease (AD). Novel MTDLs have been designed as inhibitors of human acetylcholinesterases/butyrylcholinesterases, monoamine oxidase A/B, and glycogen synthase kinase 3β and as calcium channel antagonists via the Biginelli multicomponent reaction. Among these MTDLs, (±)-BIGI-3h was identified as a promising new hit compound showing in vitro balanced activities toward the aforementioned recognized AD targets. Additional in vitro studies demonstrated antioxidant effects and brain penetration, along with the ability to inhibit the aggregation of both τ protein and β-amyloid peptide. The in vivo studies have shown that (±)-BIGI-3h (10 mg/kg intraperitoneally) significantly reduces scopolamine-induced cognitive deficits.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21018798
003      
CZ-PrNML
005      
20210830100351.0
007      
ta
008      
210728s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1021/acschemneuro.0c00803 $2 doi
035    __
$a (PubMed)33797877
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Ismaili, Lhassane $u Neurosciences intégratives et cliniques EA 481, Univ. Bourgogne Franche-Comté, F-25000 Besançon, France
245    10
$a (±)-BIGI-3h: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3β Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer's Disease / $c L. Ismaili, J. Monnin, A. Etievant, RL. Arribas, L. Viejo, B. Refouvelet, O. Soukup, J. Janockova, V. Hepnarova, J. Korabecny, T. Kucera, D. Jun, R. Andrys, K. Musilek, A. Baguet, EM. García-Frutos, A. De Simone, V. Andrisano, M. Bartolini, C. de Los Ríos, J. Marco-Contelles, E. Haffen
520    9_
$a Multitarget-directed ligands (MTDLs) are considered a promising therapeutic strategy to address the multifactorial nature of Alzheimer's disease (AD). Novel MTDLs have been designed as inhibitors of human acetylcholinesterases/butyrylcholinesterases, monoamine oxidase A/B, and glycogen synthase kinase 3β and as calcium channel antagonists via the Biginelli multicomponent reaction. Among these MTDLs, (±)-BIGI-3h was identified as a promising new hit compound showing in vitro balanced activities toward the aforementioned recognized AD targets. Additional in vitro studies demonstrated antioxidant effects and brain penetration, along with the ability to inhibit the aggregation of both τ protein and β-amyloid peptide. The in vivo studies have shown that (±)-BIGI-3h (10 mg/kg intraperitoneally) significantly reduces scopolamine-induced cognitive deficits.
650    12
$a Alzheimerova nemoc $x farmakoterapie $7 D000544
650    _2
$a blokátory kalciových kanálů $x farmakologie $x terapeutické užití $7 D002121
650    _2
$a vápníkové kanály $7 D015220
650    _2
$a cholinesterasové inhibitory $x farmakologie $x terapeutické užití $7 D002800
650    _2
$a GSK3B $7 D000071679
650    _2
$a lidé $7 D006801
650    _2
$a ligandy $7 D008024
650    _2
$a monoaminoxidasa $x metabolismus $7 D008995
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Monnin, Julie $u Neurosciences intégratives et cliniques EA 481, Univ. Bourgogne Franche-Comté, F-25000 Besançon, France
700    1_
$a Etievant, Adeline $u Neurosciences intégratives et cliniques EA 481, Univ. Bourgogne Franche-Comté, F-25000 Besançon, France
700    1_
$a Arribas, Raquel L $u Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria, Hospital Universitario de la Princesa, C/Diego de León, 62, 28006 Madrid, Spain $u Instituto Teofilo Hernando, Universidad Autónoma de Madrid, C/Arzobispo Morcillo, 4, 28029 Madrid, Spain
700    1_
$a Viejo, Lucía $u Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria, Hospital Universitario de la Princesa, C/Diego de León, 62, 28006 Madrid, Spain $u Instituto Teofilo Hernando, Universidad Autónoma de Madrid, C/Arzobispo Morcillo, 4, 28029 Madrid, Spain
700    1_
$a Refouvelet, Bernard $u Neurosciences intégratives et cliniques EA 481, Univ. Bourgogne Franche-Comté, F-25000 Besançon, France
700    1_
$a Soukup, Ondrej $u Biomedical Research Center, University Hospital Hradec Kralove, Czech Republic, University of Defence, 50003 Hradec Kralove, Czech Republic
700    1_
$a Janockova, Jana $u Biomedical Research Center, University Hospital Hradec Kralove, Czech Republic, University of Defence, 50003 Hradec Kralove, Czech Republic
700    1_
$a Hepnarova, Vendula $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, 66210 Brno, Czech Republic
700    1_
$a Korabecny, Jan $u Biomedical Research Center, University Hospital Hradec Kralove, Czech Republic, University of Defence, 50003 Hradec Kralove, Czech Republic
700    1_
$a Kucera, Tomas $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, 66210 Brno, Czech Republic
700    1_
$a Jun, Daniel $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, 66210 Brno, Czech Republic
700    1_
$a Andrys, Rudolf $u Faculty of Science, Department of Chemistry, University Hradec Kralove, Rokitanskeho 62, 50003 Hradec Kralove, Czech Republic
700    1_
$a Musilek, Kamil $u Faculty of Science, Department of Chemistry, University Hradec Kralove, Rokitanskeho 62, 50003 Hradec Kralove, Czech Republic
700    1_
$a Baguet, Aurelie $u Université Bourgogne Franche Comté, INSERM, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France
700    1_
$a García-Frutos, Eva M $u Instituto de Ciencia de Materiales de Madrid, CSIC, Cantoblanco, 28049 Madrid, Spain
700    1_
$a De Simone, Angela $u Department for Life Quality Studies, Alma Mater Studiorum University of Bologna, Corso di Augusto, 237, 47921 Rimini, Italy
700    1_
$a Andrisano, Vincenza $u Department for Life Quality Studies, Alma Mater Studiorum University of Bologna, Corso di Augusto, 237, 47921 Rimini, Italy
700    1_
$a Bartolini, Manuela $u Department of Pharmacy and Biotechnology, Alma Mater Studiorum University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy
700    1_
$a de Los Ríos, Cristóbal $u Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria, Hospital Universitario de la Princesa, C/Diego de León, 62, 28006 Madrid, Spain $u Instituto Teofilo Hernando, Universidad Autónoma de Madrid, C/Arzobispo Morcillo, 4, 28029 Madrid, Spain
700    1_
$a Marco-Contelles, José $u Laboratory of Medicinal Chemistry, Instituto de Química Orgánica General, Consejo Superior de Investigaciones Científicas, Juan de la Cierva 3, 28006 Madrid, Spain
700    1_
$a Haffen, Emmanuel $u Neurosciences intégratives et cliniques EA 481, Univ. Bourgogne Franche-Comté, F-25000 Besançon, France
773    0_
$w MED00193636 $t ACS chemical neuroscience $x 1948-7193 $g Roč. 12, č. 8 (2021), s. 1328-1342
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33797877 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830100351 $b ABA008
999    __
$a ok $b bmc $g 1689782 $s 1139244
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 12 $c 8 $d 1328-1342 $e 20210402 $i 1948-7193 $m ACS chemical neuroscience $n ACS Chem Neurosci $x MED00193636
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Možnosti archivace